Stocktoria

Vir Biotechnology, Inc. VIR

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-11

Vir Biotechnology, Inc. statistics & valuation

Market cap$1.5B
P / S21.2×
P / B1.9×
Net margin-638.9%
Return on equity-57.2%
FCF margin-578.5%
Return on capital-52.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1086.30% -2159.00% -391.10% 48.30% 31.90% -713.70% -703.40% -638.90% 20182019202020212022202320242025
Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
-1112.60% -2199.70% -388.90% 38.40% 51.60% -794.00% -791.30% -699.20% 20182019202020212022202320242025
Return on equity (%)
-41.20% -41.70% 36.90% 24.80% -38.70% -45.40% -57.20% 20182019202020212022202320242025
Shares outstanding
8.9M 107.6M 127.4M 133.4M 134.8M 134.8M 137.0M 139.5M 20182019202020212022202320242025
Net debt ($)
20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-60.50% -34.10% -32.50% 27.00% 18.40% -32.10% -37.30% -43.70% 20182019202020212022202320242025
Free cash flow margin (%)
-958.80% -1712.70% -258.60% -6.30% 98.70% -928.70% -611.40% -578.50% 20182019202020212022202320242025
Debt / equity (×)
20182019202020212022202320242025
EPS ($)
-$5.76 -$2.51 $3.96 $3.83 -$4.59 -$3.83 -$3.16 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin-699.2%-791.3%-794.0%51.6%38.4%-388.9%-2199.7%-1112.6%
Net margin-638.9%-703.4%-713.7%31.9%48.3%-391.1%-2159.0%-1086.3%
FCF margin-578.5%-611.4%-928.7%98.7%-6.3%-258.6%-1712.7%-958.8%
Return on assets-43.7%-37.3%-32.1%18.4%27.0%-32.5%-34.1%-60.5%
Return on equity-57.2%-45.4%-38.7%24.8%36.9%-41.7%-41.2%64.7%
Current ratio5.548.719.054.934.587.806.812.95

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.